Faculty Publications

HER2 predicts benefit from adjuvant paclitaxel after AC in node-positive breast cancer: CALGB 9344

Hayes DF, Thor A, Dressler L, Weaver D, Broadwater G, Goldstein L, Martino S, Ingle J, Henderson IC, Berry D

HER2 predicts benefit from adjuvant paclitaxel after AC in node-positive breast cancer: CALGB 9344

J Clin Oncol. 2006 Jun;24(18):5S-5S.

Abstract

Last updated on Saturday, November 21, 2009